Please login to the form below

Not currently logged in

S-A extends Genzyme offer deadline

Sanofi-aventis has pushed back the deadline for Genzyme's shareholders to tender their stock from December 10 to January 21

Sanofi-aventis (S-A) has pushed back the deadline for Genzyme's shareholders to tender their stock from December 10 to January 21.

S-A took its offer directly to Genzyme's shareholders in October, saying that the company's board had refused to take part in serious discussions.

Genzyme's management took the news of the extended deadline as evidence that they have been correct in asserting that S-A's offer is too low. "The results of the tender offer reported today demonstrate that our shareholders strongly support the view of the board that the sanofi offer substantially undervalues Genzyme," company CEO Henri Termeer said in a statement. "We continue to have the support of our shareholders (and) are open to a transaction that appropriately recognises Genzyme's intrinsic value and prospects."

S-A's bid for the biotech company turned hostile in April after talks between the companies fell apart. The $69 per share bid is a 31 per cent premium over Genzyme's one-month average up until the day before rumors of the takeover surfaced.
Analysts have predicted that a successful takeover of Genzyme will cost S-A as much as $77 per share.

The takeover would allow S-A to diversify its portfolio and provide it with access to Genzyme's drugs for rare diseases, which are less vulnerable than its own to generic competition. If successful, this will be the largest hostile takeover since Roche Holdings acquired Genentech for $47bn in 2008.

13th December 2010


COVID-19 Updates and Daily News

Featured jobs


Add my company

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...